BRK-B vs PFX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
PFX exhibits severe fundamental distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of improvement across all key financial health metrics. While the stock trades at a discount to book value (P/B 0.53), this is offset by negative net profit margins and a catastrophic Q/Q revenue decline of 149.52%. Despite recent EPS beats, the high PEG ratio (8.40) and a 0/100 technical trend suggest the market is pricing in significant risk. The combination of fundamental decay and bearish price action makes this a high-risk asset.
Compare Another Pair
Related Comparisons
BRK-B vs PFX: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and PhenixFIN Corporation (PFX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.